Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Bullboard Posts
Post by ezemoneyon Apr 29, 2020 4:51am
177 Views
Post# 30964957

They Are On The Right Path

They Are On The Right Path


A British trade publication for health-care professionals has just issued an extremely ominous warning. While the world is fixated on battling the coronavirus, a small group of British children have exhibited a mysterious new respiratory syndrome.

According to the Health Service Journal, the Department of Health and Social Care has sent an urgent alert to general practitioners and pediatricians across Britain last week warning about a "serious coronavirus-related syndrome [that] may be emerging in the UK."

The alert comes following a suspicious spike in alarming respiratory cases in children, who typically don't exhibit severe coronavirus symptoms, though children as young as a few months have died due to complications related to the coronavirus.

Though the warning identifies the new syndrome as coronavirus-related, it adds later down that the new inflammatory syndrome could even be an entirely new pathogen.

A British trade publication for health-care professionals has just issued an extremely ominous warning. While the world is fixated on battling the coronavirus, a small group of British children have exhibited a mysterious new respiratory syndrome.

According to the Health Service Journal, the Department of Health and Social Care has sent an urgent alert to general practitioners and pediatricians across Britain last week warning about a "serious coronavirus-related syndrome [that] may be emerging in the UK."

The alert comes following a suspicious spike in alarming respiratory cases in children, who typically don't exhibit severe coronavirus symptoms, though children as young as a few months have died due to complications related to the coronavirus.

Though the warning identifies the new syndrome as coronavirus-related, it adds later down that the new inflammatory syndrome could even be an entirely new pathogen.

Bullboard Posts